Inhibition of the CXCL12–CXCR4 Signaling Pathway by M2pep‐Cs NPs/Plerixafor NPs Enhances Immune Recognition and Suppresses Tumor Growth in a GC Mouse Model. Here, CXCL12 is linked to neoplasm.